EMERSON ELECTRIC CO.

EMR · CIK 0000032604

19 fiscal years · 68 SEC filings · every number carries its receipt

Revenue (FY)

$18.02B3.0%

FY2025

Net income (FY)

$2.29B16.5%

FY2025

Free cash flow (FY)

$2.67B8.4%

FY2025

Diluted EPS (FY)

$4.0417.8%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

net margin 9.7% → 12.7%

MarginsNet marginFCF margin

FY2025: net 12.7% · free cash flow 14.8% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $3.10B operating cash − $431.0M capex = $2.67B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 26% (FY2008) → 11% (FY2025) · on assets 5.5%

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Revenue	4,562	4,346	4,553	4,432	4,175	4,380	4,376	4,117	3,946	3,756	3,373	3,465
Net income	618	605	586	485	585	329	501	142	9,352	792	2,331	921
Diluted EPS	—	1.07	1.04	0.86	1.02	0.57	0.87	0.25	16.28	1.38	3.97	1.54
Diluted shares	563	564	565	565	571	575	574	573	574	574	587	596
Operating cash flow	—	699	—	—	777	—	—	415	—	—	418	—
Capital expenditures	—	97	—	—	83	—	—	77	—	—	59	—
Free cash flow	—	602	—	—	694	—	—	338	—	—	359	—
Cash & equivalents	1,791	1,748	2,219	1,887	2,834	2,298	2,318	2,076	9,957	2,046	2,271	2,529
Total assets	42,088	41,939	42,517	41,978	42,610	45,585	46,440	46,513	44,173	36,147	36,241	37,042
Shareholders' equity	20,303	20,277	19,870	19,249	20,490	20,799	20,900	20,674	20,464	11,360	10,727	10,315

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. Quarterly view shows as-reported 10-Q periods; Q4 synthesis ships in Phase 1. See methodology.